To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPL8TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
388 representative clones for gene RPL8 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CB124694 Liver .a 1 to 163 1 to 163   tiling clone,   163/163
(100 %)
0 diff
(100 %id)
BP871924 embryonal kidney .a 2 to 581 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
BI862141 breast, mammary adenocarcinoma, cell line .a 11 to 732 24 to 745       722/747
(96 %)
10 diff
(98.7 %id)
TI_57193484   .a 11 to 732 45 to 766       722/747
(96 %)
10 diff
(98.7 %id)
CF619043 Pooled Chondrosarcoma Tumor cells .a 14 to 795 9 to 802       794/855
(92 %)
31 diff
(96.4 %id)
BQ929065 carcinoma, cell line, Prostate .a 15 to 887 1 to 881   tiling clone,   881/889
(99 %)
12 diff
(98.7 %id)
BM792255 Ascites, stomach .a 17 to 678 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BE253346 eye, retinoblastoma .a 34 to 602 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BE253400 eye, retinoblastoma .a 36 to 712 1 to 674       674/674
(100 %)
6 diff
(99.2 %id)
BG767321 melanotic melanoma, high MDR (cell line), skin .a 51 to 805 1 to 750       750/752
(99 %)
18 diff
(97.7 %id)
BM693717 eye, lens .a 110 to 594 1 to 422   fully sequenced,   422/422
(100 %)
0 diff
(100 %id)
BM670859 eye, lens .a 494 to 925 450 to 19   tiling clone, fully sequenced, AAA   432/432
(100 %)
0 diff
(100 %id)
CA946955 Pancreas, Purified pancreatic islet .b 1 to 409 1 to 409   tiling clone,   409/409
(100 %)
1 diff
(99.8 %id)
BM915353 amelanotic melanoma, cell line, skin .b 5 to 840 1 to 843       843/1072
(78 %)
15 diff
(98.7 %id)
BM452986 leiomyosarcoma, uterus .b 9 to 728 1 to 718       718/1077
(66 %)
14 diff
(98.8 %id)
BG480561 choriocarcinoma, placenta .b 13 to 702 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
BM844067 myeloma .b 14 to 557 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
BU538563 adenocarcinoma, cell line, breast .b 15 to 813 1 to 799       799/979
(81 %)
9 diff
(99.1 %id)
BM549515 astrocytoma grade IV, cell line, brain .b 19 to 669 1 to 652       652/1100
(59 %)
11 diff
(99.0 %id)
BU858150 adenocarcinoma, cell line, breast .b 34 to 715 1 to 689       689/901
(76 %)
23 diff
(97.5 %id)
BM553005 amelanotic melanoma, cell line, skin .b 36 to 1034 1 to 1004 R193K N194D G201X G212W G213R ... tiling clone, AAA   1004/1004
(100 %)
20 diff
(98.1 %id)
BQ926694 large cell carcinoma, lung .b 41 to 841 1 to 803       803/955
(84 %)
6 diff
(99.4 %id)
BG122353 adenocarcinoma, cell line, Liver .b 178 to 896 1 to 714   AAA   716/818
(87 %)
15 diff
(98.2 %id)
BF037990 adenocarcinoma, ovary .b 179 to 773 1 to 593       593/593
(100 %)
5 diff
(99.2 %id)
BM791431 stomach .b 196 to 809 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BI765636 pooled colon, kidney, stomach .b 198 to 1020 28 to 850 exact     823/856
(96 %)
7 diff
(99.2 %id)
TI_57146973   .b 198 to 1020 28 to 850 exact     823/856
(96 %)
7 diff
(99.2 %id)
CB138873 Liver .b 201 to 738 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
CN424173 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 205 to 801 1 to 597       597/597
(100 %)
5 diff
(99.2 %id)
CA946684 Pancreas, Purified pancreatic islet .b 436 to 1035 605 to 6   tiling clone,   600/607
(98 %)
5 diff
(99.2 %id)
CB128790 Liver .c 1 to 543 1 to 543   tiling clone,   543/543
(100 %)
1 diff
(99.9 %id)
BU507246 leiomyosarcoma, uterus .c 13 to 768 1 to 764       764/880
(86 %)
15 diff
(98.3 %id)
CD048344 embryonic stem cells, WA01, passage 38 .c 19 to 912 19 to 923       905/923
(98 %)
32 diff
(96.6 %id)
CD048543 embryonic stem cells, WA01, passage 38 .c 19 to 828 14 to 828       815/887
(91 %)
13 diff
(98.6 %id)
CD248815 embryonic stem cells, WA01, passage 38 .c 21 to 822 24 to 834       809/842
(96 %)
24 diff
(97.2 %id)
BU845271 ovary, teratocarcinoma, cell line .c 21 to 926 1 to 915       915/937
(97 %)
21 diff
(97.8 %id)
BG437390 large cell carcinoma, lung .c 22 to 777 1 to 764       764/914
(83 %)
22 diff
(97.6 %id)
BQ214454 melanotic melanoma, skin .c 22 to 770 1 to 754       754/879
(85 %)
30 diff
(96.6 %id)
BU855592 ovary, teratocarcinoma, cell line .c 22 to 878 35 to 901       867/906
(95 %)
21 diff
(97.7 %id)
BU844772 ovary, teratocarcinoma, cell line .c 27 to 903 30 to 911       882/915
(96 %)
19 diff
(98.0 %id)
CD249672 embryonic stem cells, WA01, passage 38 .c 30 to 845 23 to 851       827/911
(90 %)
24 diff
(97.4 %id)
BQ277857 ovary, teratocarcinoma, cell line .c 30 to 969 1 to 940 E254G K255E E256R N257E AAA   940/940
(100 %)
9 diff
(99.1 %id)
BU849490 ovary, teratocarcinoma, cell line .c 30 to 897 1 to 873       873/874
(99 %)
11 diff
(98.8 %id)
BM006040 hepatocellular carcinoma, cell line, Liver .c 31 to 759 1 to 728       728/732
(99 %)
12 diff
(98.4 %id)
CD248880 embryonic stem cells, WA01, passage 38 .c 32 to 808 21 to 799       779/880
(88 %)
10 diff
(98.9 %id)
TI_59385993   .c 32 to 759 66 to 792       727/731
(99 %)
11 diff
(98.5 %id)
BQ652020 hepatocellular carcinoma, cell line, Liver .c 33 to 771 1 to 739       739/919
(80 %)
24 diff
(97.4 %id)
BM555229 amelanotic melanoma, cell line, skin .c 36 to 765 1 to 737       737/1098
(67 %)
20 diff
(98.2 %id)
BM559247 amelanotic melanoma, cell line, skin .c 36 to 962 1 to 934 S223F R241P R242P Q253P E254G ...     934/996
(93 %)
12 diff
(98.8 %id)
EL955348 eyeball .c 37 to 488 8 to 459       452/459
(98 %)
6 diff
(98.7 %id)
BF338143 brain, glioblastoma with EGFR amplification .c 38 to 128 5 to 95       91/95
(95 %)
6 diff
(93.7 %id)
BE746514 adenocarcinoma cell line, ovary .c 42 to 796 1 to 747       749/747
(100 %)
10 diff
(98.7 %id)
BM474290 eye, retinoblastoma .c 43 to 925 1 to 888       888/1029
(86 %)
12 diff
(98.9 %id)
BG821983 adenocarcinoma cell line, colon .c 45 to 874 1 to 843       843/846
(99 %)
25 diff
(97.1 %id)
BG765543 melanotic melanoma, high MDR (cell line), skin .c 45 to 771 1 to 726       726/869
(83 %)
5 diff
(99.5 %id)
BC012197 Skin, melanotic melanoma. .c 46 to 964 1 to 919 I98V tiling clone, available from MGC, AAA   919/919
(100 %)
1 diff
(99.9 %id)
CN481279 eye .c 46 to 620 1 to 575       575/575
(100 %)
0 diff
(100 %id)
NM_033301.1   .c 46 to 964 1 to 919 exact RefSeq, AAA   919/919
(100 %)
0 diff
(100 %id)
DN994397 brain, whole brain .c 46 to 607 9 to 570       562/570
(98 %)
0 diff
(100 %id)
BQ065421 lymph, lymphoma, cell line .c 47 to 883 1 to 840       840/1060
(79 %)
13 diff
(98.8 %id)
BQ674122 epidermoid carcinoma, cell line, salivary gland .c 49 to 926 1 to 884   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 884/973
(90 %)
24 diff
(97.6 %id)
BQ672508 epidermoid carcinoma, cell line, salivary gland .c 49 to 748 1 to 712       712/946
(75 %)
13 diff
(98.7 %id)
BU538217 adenocarcinoma, cell line, breast .c 49 to 962 1 to 931 K155Q G167W V168C V169G A170G ...     931/957
(97 %)
47 diff
(95.1 %id)
BU538370 adenocarcinoma, cell line, breast .c 49 to 907 1 to 872       872/988
(88 %)
23 diff
(97.7 %id)
BM045303 carcinoma, cell line, Prostate .c 50 to 948 1 to 900 H139Q N140Q A161G A185G Y186V ...     900/938
(95 %)
37 diff
(96.1 %id)
BM553943 amelanotic melanoma, cell line, skin .c 51 to 429 18 to 396       379/1326
(28 %)
8 diff
(99.4 %id)
BG437883 large cell carcinoma, lung .c 54 to 938 1 to 893 S130F G131R N132E Y133L A134C ...     893/899
(99 %)
21 diff
(97.7 %id)
BM046483 carcinoma, cell line, Prostate .c 54 to 827 1 to 766       770/888
(86 %)
18 diff
(98.0 %id)
TI_57146961   .c 63 to 660 26 to 622       597/622
(95 %)
9 diff
(98.6 %id)
BG291044 bladder, transitional cell papilloma, cell line .c 64 to 128 1 to 65       65/65
(100 %)
0 diff
(100 %id)
BQ920769 carcinoma, cell line, Prostate .c 65 to 964 1 to 902 N215T H216T Q217S H218T I219S ...     902/963
(93 %)
12 diff
(98.8 %id)
BU194745 melanotic melanoma, skin .c 86 to 864 1 to 795       795/845
(94 %)
27 diff
(96.9 %id)
BE277099 melanotic melanoma, skin .c 87 to 920 1 to 830       834/835
(99 %)
28 diff
(96.7 %id)
BE741206 adenocarcinoma cell line, ovary .c 88 to 826 1 to 737       737/745
(98 %)
7 diff
(99.1 %id)
BE743442 adenocarcinoma cell line, ovary .c 89 to 771 1 to 679       679/682
(99 %)
5 diff
(99.3 %id)
BU857226 adenocarcinoma, cell line, breast .c 99 to 964 1 to 872 T249N K250Q T251D V252W Q253A ... tiling clone,   872/923
(94 %)
11 diff
(98.9 %id)
BI461661 testis .d 1 to 851 1 to 842   tiling clone,   842/855
(98 %)
22 diff
(97.5 %id)
BC093064 Spinal cord .d 32 to 905 1 to 874 exact AAA   874/874
(100 %)
0 diff
(100 %id)
NM_000973.3   .d 32 to 905 1 to 874 exact RefSeq, AAA   874/874
(100 %)
0 diff
(100 %id)
BQ049126 lymph, lymphoma, cell line .d 37 to 903 1 to 880 S223L T224H I225N R226P R227Q ...     880/1046
(84 %)
23 diff
(97.9 %id)
AK289459   .d 55 to 905 1 to 851 exact     851/851
(100 %)
1 diff
(99.9 %id)
BQ061958 lymph, lymphoma, cell line .d 58 to 906 1 to 848 S223L R242P T243D G244W R245T ... AAA   848/848
(100 %)
10 diff
(98.9 %id)
TI_154192025   .d 61 to 905 923 to 81 G2X G7D Q8T G11A A12P ... AAA Submitted on the opposite strand 843/1017
(82 %)
8 diff
(99.3 %id)
TI_149273440   .d 62 to 712 51 to 702     Submitted on the opposite strand 652/1023
(63 %)
28 diff
(97.3 %id)
TI_149306185   .d 62 to 904 61 to 901 K188X K192X Q217S H218T I219S ...   Submitted on the opposite strand 841/1072
(78 %)
18 diff
(98.4 %id)
TI_159700021   .d 62 to 905 59 to 903 V148C K149E L150A P151A S152L ... AAA Submitted on the opposite strand 845/903
(93 %)
26 diff
(97.2 %id)
BE744088 adenocarcinoma cell line, ovary .d 64 to 895 17 to 852 N215T H216T Q217S H218T I219S ...     836/877
(95 %)
27 diff
(97.0 %id)
Z28407 ovary .d 67 to 906 13 to 852 exact     840/852
(98 %)
6 diff
(99.3 %id)
BU506903 leiomyosarcoma, uterus .d 68 to 905 6 to 844 G201X R245H T249N K250Q T251D ... AAA   839/844
(99 %)
8 diff
(99.1 %id)
BM469787 lymph, lymphoma, cell line .d 69 to 908 10 to 849 R233P G248E T249P T251M V252C ...     840/1017
(82 %)
27 diff
(97.4 %id)
TI_59386020   .d 69 to 906 43 to 878 I179S L180*     836/882
(94 %)
22 diff
(97.6 %id)
BC000077 Kidney, renal cell adenocarcinoma .d 71 to 905 1 to 835 exact available from MGC, AAA   835/835
(100 %)
0 diff
(100 %id)
BQ961989 epithelioid carcinoma cell line, Pancreas .d 71 to 906 1 to 835 G236X G248X N257D     835/840
(99 %)
6 diff
(99.3 %id)
TI_57151747   .d 71 to 906 62 to 896 T224S P230L A231L G232A R233A ...     835/938
(89 %)
16 diff
(98.3 %id)
TI_57180036   .d 71 to 900 54 to 883 K221Q P222A S223L T224H I225H ... AAA   830/888
(93 %)
13 diff
(98.6 %id)
TI_57181869   .d 71 to 905 29 to 862 P230L A231L G232A R233A V235W ... AAA   834/862
(96 %)
9 diff
(99.0 %id)
TI_44459096   .d 71 to 906 59 to 897 S223P T224P I225S R226A R227E ...     839/913
(91 %)
12 diff
(98.7 %id)
BY795042 eye .d 72 to 905 1 to 834 exact AAA   834/834
(100 %)
0 diff
(100 %id)
BM462271 eye, retinoblastoma .d 72 to 905 35 to 867 K250R T251L V252C E254R E256R ... AAA   833/867
(96 %)
15 diff
(98.3 %id)
BM476460 lymph, lymphoma, cell line .d 72 to 911 25 to 866 T249N K250Q T251D V252C Q253A ...     842/1026
(82 %)
13 diff
(98.8 %id)
BM907244 large cell carcinoma, lung .d 72 to 905 1 to 836 T243D G244W R245T L246S R247P ...     836/986
(84 %)
11 diff
(98.9 %id)
BQ233740 epithelioid carcinoma, Pancreas .d 72 to 905 1 to 836 K250X AAA   836/836
(100 %)
5 diff
(99.5 %id)
BQ224323 large cell carcinoma, lung .d 72 to 908 1 to 845 T249N K250Q T251D V252C Q253A ...     845/875
(96 %)
9 diff
(99.0 %id)
BU951099 Pancreas, Purified pancreatic islet .d 72 to 627 3 to 559   fully sequenced,   557/559
(99 %)
6 diff
(99.0 %id)
BU507781 leiomyosarcoma, uterus .d 72 to 906 6 to 842 G212W G213R G214W N215Q H216P ... AAA   837/842
(99 %)
16 diff
(98.1 %id)
AW160571 brain, frontal lobe .d 73 to 502 1 to 430   fully sequenced,   430/430
(100 %)
3 diff
(99.4 %id)
BG823294 adenocarcinoma cell line, colon .d 73 to 905 1 to 832 G212R G213R G214W N215Q T224N ...     832/901
(92 %)
10 diff
(98.9 %id)
BM559309 amelanotic melanoma, cell line, skin .d 73 to 906 1 to 843 P197A G213S R227Q D228R A229C ... AAA   843/1024
(82 %)
20 diff
(98.1 %id)
BM471623 leiomyosarcoma, uterus .d 73 to 899 13 to 853 R200T G212W G213R G214W N215Q ...     841/1092
(77 %)
25 diff
(97.8 %id)
BU500391   .d 73 to 906 1 to 838 V199X R200T A203W M204P N205* AAA   838/838
(100 %)
12 diff
(98.6 %id)
TI_59381640   .d 73 to 866 104 to 908       805/806
(99 %)
17 diff
(97.9 %id)
BM708883 eye, RPE and Choroid .d 73 to 484 1 to 412   fully sequenced,   412/412
(100 %)
0 diff
(100 %id)
BC002423 Brain, neuroblastoma .d 74 to 905 1042 to 1873 exact tiling clone, AAA   832/1873
(44 %)
0 diff
(100 %id)
BM458616 lymph, lymphoma, cell line .d 74 to 906 1 to 834 exact     834/836
(99 %)
4 diff
(99.6 %id)
BM461962 leiomyosarcoma, uterus .d 74 to 910 1 to 837 R233P K234Q R245H N257T     837/891
(93 %)
7 diff
(99.3 %id)
BQ072987 leukocyte .d 74 to 906 1 to 833 T249N     833/1059
(78 %)
4 diff
(99.7 %id)
BQ068746 brain, neuroblastoma, cell line .d 74 to 903 1 to 832 E256K     832/976
(85 %)
5 diff
(99.5 %id)
BU839604 hepatocellular carcinoma, cell line, Liver .d 74 to 902 1 to 841 H216T Q217S H218T I219S G220A ...     841/942
(89 %)
16 diff
(98.4 %id)
BQ681573 melanotic melanoma, cell line, skin .d 74 to 905 6 to 838 R242P T243D G244W R245T L246S ... AAA   833/838
(99 %)
12 diff
(98.6 %id)
BU932011 ovary, teratocarcinoma, cell line .d 74 to 905 1 to 838 G201X S223L E254G K255E E256R ...     838/844
(99 %)
13 diff
(98.5 %id)
BC015588 Skin, melanotic melanoma. .d 75 to 905 876 to 46 exact AAA Submitted on the opposite strand 831/1234
(67 %)
2 diff
(99.9 %id)
BI333218 cervical carcinoma cell line, cervix .d 75 to 905 1 to 832 G220R K221Q P222A S223L T224H ...     832/832
(100 %)
6 diff
(99.3 %id)
BM563552 astrocytoma grade IV, cell line, brain .d 75 to 905 1 to 831 S223L T224H I225H R226P R227Q ... AAA   831/831
(100 %)
5 diff
(99.4 %id)
BM560095 amelanotic melanoma, cell line, skin .d 75 to 905 24 to 855 K250R T251L V252C Q253R E254R ... AAA   832/855
(97 %)
6 diff
(99.3 %id)
BM552785 astrocytoma grade IV, cell line, brain .d 75 to 905 1 to 831 G201X T249P K250R T251L V252C ... AAA   831/831
(100 %)
4 diff
(99.6 %id)
BM424252 amelanotic melanoma, cell line, skin .d 75 to 905 1 to 831 G248X     831/1046
(79 %)
4 diff
(99.7 %id)
BM801063 embryonal carcinoma, cell line, testis .d 75 to 897 1 to 830 G212W G213R G214W N215A H216T ...     830/1040
(79 %)
40 diff
(96.2 %id)
BQ219640 epithelioid carcinoma, Pancreas .d 75 to 905 1 to 836 E254G K255E E256R N257E     836/862
(96 %)
11 diff
(98.8 %id)
BQ222233 epithelioid carcinoma, Pancreas .d 75 to 905 1 to 833 Q253A E254G K255E E256R N257E AAA   833/833
(100 %)
4 diff
(99.6 %id)
BQ439396 epithelioid carcinoma, Pancreas .d 75 to 899 1 to 846 V199X R200Y A203W M204P N205X ...     844/902
(93 %)
25 diff
(97.3 %id)
BQ228309 epithelioid carcinoma, Pancreas .d 75 to 905 1 to 832 L246X     832/870
(95 %)
5 diff
(99.5 %id)
BQ233016 epithelioid carcinoma, Pancreas .d 75 to 905 1 to 835 T249N K250Q T251D V252C Q253A ... AAA   835/837
(99 %)
10 diff
(98.9 %id)
BQ216921 large cell carcinoma, lung .d 75 to 911 1 to 837 exact AAA   837/837
(100 %)
3 diff
(99.7 %id)
BQ233072 large cell carcinoma, lung .d 75 to 905 1 to 831 G201X AAA   831/831
(100 %)
0 diff
(100 %id)
BU164903 eye, retinoblastoma .d 75 to 919 1 to 848 T243N R245T L246S R247P T249N ...     848/916
(92 %)
20 diff
(97.9 %id)
BU154229 eye, retinoblastoma .d 75 to 905 1 to 834 W196X P197A R198T V199S R200T ... AAA   834/834
(100 %)
6 diff
(99.3 %id)
BQ959770 leiomyosarcoma, uterus .d 75 to 905 1 to 835 W196X P197A R198T V199S R200N ... AAA   835/835
(100 %)
8 diff
(99.1 %id)
CD108166 brain, Pituitary .d 75 to 905 1 to 836 Q253P N257K     836/862
(96 %)
8 diff
(99.1 %id)
CD108099 brain, Pituitary .d 75 to 905 1 to 834 N257D     834/838
(99 %)
7 diff
(99.2 %id)
AW163650 brain, frontal lobe .d 76 to 408 1 to 333   fully sequenced,   333/333
(100 %)
0 diff
(100 %id)
BM908754 astrocytoma grade IV, cell line, brain .d 76 to 906 1 to 833 G201X K250Q E256K N257K AAA   833/833
(100 %)
11 diff
(98.7 %id)
BM809659 amelanotic melanoma, cell line, skin .d 76 to 906 24 to 860 G212W G213K G214W N215Q H216P ...     837/865
(96 %)
15 diff
(98.3 %id)
BM914835 amelanotic melanoma, cell line, skin .d 76 to 901 1 to 830 V199X R200Y A203W M204P N205*     830/1072
(77 %)
14 diff
(98.7 %id)
BM915454 amelanotic melanoma, cell line, skin .d 76 to 905 1 to 833 G201X G212W G213R G214W N215Q ... AAA   833/833
(100 %)
8 diff
(99.1 %id)
BQ055869 lymph, lymphoma, cell line .d 76 to 908 1 to 843 V235G A239G A240C R241P R242P ...     843/1102
(76 %)
19 diff
(98.3 %id)
BQ057797 lymph, lymphoma, cell line .d 76 to 905 1 to 833 G248X Q253X     833/837
(99 %)
5 diff
(99.5 %id)
BQ061014 lymph, lymphoma, cell line .d 76 to 905 1 to 831 H216T Q217S H218T I219S G220A ...     831/1053
(78 %)
11 diff
(99.0 %id)
BQ065605 lymph, lymphoma, cell line .d 76 to 905 1 to 830 K250R T251L V252C Q253R E254R ...     830/1022
(81 %)
3 diff
(99.8 %id)
BU162639 hepatocellular carcinoma, cell line, Liver .d 76 to 905 1 to 831 A240P     831/835
(99 %)
3 diff
(99.7 %id)
BQ642945 lymph, lymphoma, cell line .d 76 to 906 1 to 835 P197X R198T V199S R200T A203W ...     835/933
(89 %)
15 diff
(98.4 %id)
BQ643465 lymph, lymphoma, cell line .d 76 to 905 1 to 833 A203G G248X T249N K250Q T251D ...     833/933
(89 %)
9 diff
(99.1 %id)
BQ944102 large cell carcinoma, lung .d 76 to 905 1 to 832 G201X T249N E256K AAA   832/832
(100 %)
8 diff
(99.1 %id)
BQ919555 carcinoma, cell line, Prostate .d 76 to 910 1 to 832 D228C A229P P230C A231W G232P ... AAA   832/832
(100 %)
5 diff
(99.4 %id)
BQ941686 large cell carcinoma, lung .d 76 to 905 1 to 830 G201X K250X     830/833
(99 %)
1 diff
(99.9 %id)
BQ937086 carcinoma, cell line, Prostate .d 76 to 911 1 to 838 G201X D228C A229P P230C A231W ... AAA   838/838
(100 %)
8 diff
(99.1 %id)
BU527160 epidermoid carcinoma, cell line, lung .d 76 to 908 1 to 837 T243D G244W R245T L246S R247P ...     837/842
(99 %)
6 diff
(99.3 %id)
BU538337 adenocarcinoma, cell line, breast .d 76 to 905 1 to 835 R241P R242P T243D G244W R245T ...     835/972
(85 %)
12 diff
(98.8 %id)
CD515528 White Matter .d 76 to 906 27 to 858 R241P R247G T249N     832/881
(94 %)
7 diff
(99.3 %id)
BE018745 cervix .d 77 to 502 1 to 426   fully sequenced,   426/426
(100 %)
0 diff
(100 %id)
BG912650 anaplastic oligodendroglioma with 1p/19qloss, brain .d 77 to 905 1 to 834 N140X G212W G213R G214W N215Q ... AAA   834/834
(100 %)
13 diff
(98.5 %id)
BM800417 leiomyosarcoma, uterus .d 77 to 910 1 to 834 R245H R247P T249N AAA   834/834
(100 %)
4 diff
(99.6 %id)
BQ959765 leiomyosarcoma, uterus .d 77 to 903 1 to 829 K234Q Q253P E254G K255E N257T     829/837
(99 %)
12 diff
(98.6 %id)
TI_57180817   .d 77 to 881 30 to 839 N215K H216Q V235A T249N K250Q ...     810/839
(96 %)
10 diff
(98.9 %id)
CA388834 eye, RPE/choroid .d 78 to 459 1 to 382   fully sequenced,   382/382
(100 %)
0 diff
(100 %id)
BM909688 astrocytoma grade IV, cell line, brain .d 78 to 905 23 to 863 G212W G213R G214W N215Q H216T ...     841/1108
(75 %)
22 diff
(98.1 %id)
BM554233 amelanotic melanoma, cell line, skin .d 78 to 906 26 to 854 S223L G248X K250X Q253X     829/859
(96 %)
4 diff
(99.6 %id)
BM810217 amelanotic melanoma, cell line, skin .d 78 to 906 1 to 829 G213R G214W N215Q H216P Q217P ...     829/834
(99 %)
11 diff
(98.7 %id)
BM558330 amelanotic melanoma, cell line, skin .d 78 to 905 1 to 829 S223L T224H T249N K255E E256R ...     829/1074
(77 %)
6 diff
(99.5 %id)
BM558227 astrocytoma grade IV, cell line, brain .d 78 to 905 1 to 830 T249N Q253H E254G K255E E256R ... AAA   830/830
(100 %)
6 diff
(99.3 %id)
BM916469 amelanotic melanoma, cell line, skin .d 78 to 906 1 to 839 V199I R200T A203W M204A N205M ... AAA   839/839
(100 %)
21 diff
(97.5 %id)
BQ059432 lymph, lymphoma, cell line .d 78 to 905 1 to 829 T243D G244W R245T L246S R247P ...     829/830
(99 %)
4 diff
(99.6 %id)
BQ642953 lymph, lymphoma, cell line .d 78 to 905 1 to 831 G201X R247P T249N K250Q T251D ...     831/952
(87 %)
7 diff
(99.3 %id)
BQ957763 large cell carcinoma, lung .d 78 to 908 1 to 833 G212W G213R G214W N215Q H216P ...     833/856
(97 %)
9 diff
(99.0 %id)
BQ895966 carcinoma, cell line, Prostate .d 78 to 905 1 to 835 V202C A203G M204H N205E P206S ... AAA   835/835
(100 %)
13 diff
(98.5 %id)
BQ941542 large cell carcinoma, lung .d 78 to 906 1 to 830 R241P T249N     830/838
(99 %)
6 diff
(99.3 %id)
BU956505 adenocarcinoma, cell line, breast .d 78 to 906 1 to 832 T249N V252X Q253A E254G K255E ... AAA   832/832
(100 %)
7 diff
(99.2 %id)
TI_59384513   .d 78 to 906 61 to 886 Y189X K190*     826/839
(98 %)
17 diff
(98.0 %id)
TI_59380839   .d 78 to 901 100 to 923 N140X S223P T224P I225S R226V ...     824/829
(99 %)
8 diff
(99.1 %id)
BM910645 astrocytoma grade IV, cell line, brain .d 79 to 906 1 to 831 G212W G213R G214W N215X H216P ... AAA   831/831
(100 %)
11 diff
(98.7 %id)
BM810247 amelanotic melanoma, cell line, skin .d 79 to 905 1 to 831 F211X G212W G213R G214W N215Q ...     831/832
(99 %)
19 diff
(97.8 %id)
BM561128 amelanotic melanoma, cell line, skin .d 79 to 911 1 to 833 exact     833/833
(100 %)
1 diff
(99.9 %id)
BM915917 amelanotic melanoma, cell line, skin .d 79 to 905 1 to 834 V199G R200T A203W M204P N205*     834/1039
(80 %)
22 diff
(97.9 %id)
BU184681 melanotic melanoma, cell line, skin .d 79 to 905 1 to 831 T249N K255E E256R N257E     831/833
(99 %)
8 diff
(99.1 %id)
BU170283 epithelioid carcinoma, Pancreas .d 79 to 906 1 to 834 T224H D228R A229C A231C G232W ...     834/842
(99 %)
24 diff
(97.2 %id)
BU949015 Pancreas, Purified pancreatic islet .d 79 to 627 3 to 551   fully sequenced,   549/551
(99 %)
0 diff
(100 %id)
BQ672023 epidermoid carcinoma, cell line, salivary gland .d 79 to 905 1 to 840 R233P K234Q V235R L237V I238S ...     840/905
(92 %)
21 diff
(97.7 %id)
BQ683611 melanotic melanoma, cell line, skin .d 79 to 905 1 to 829 L237S I238H A239C A240C R241P ...     829/983
(84 %)
9 diff
(99.1 %id)
BQ917975 large cell carcinoma, lung .d 79 to 905 1 to 832 S223L L237S I238H A239C A240W ...     832/838
(99 %)
9 diff
(99.0 %id)
TI_154061476   .d 79 to 905 926 to 106 G2A R3V V4* AAA   821/939
(87 %)
16 diff
(98.3 %id)
BM910623 astrocytoma grade IV, cell line, brain .d 80 to 910 1 to 832 G201X AAA   832/832
(100 %)
1 diff
(99.9 %id)
BM810114 amelanotic melanoma, cell line, skin .d 80 to 910 1 to 833 Q217S H218T I219S G220A K221S ... AAA   833/833
(100 %)
11 diff
(98.7 %id)
BM808916 amelanotic melanoma, cell line, skin .d 80 to 910 1 to 834 Q253P E254G K255E E256R N257E AAA   834/834
(100 %)
4 diff
(99.6 %id)
BQ073493 epidermoid carcinoma, cell line, lung .d 80 to 905 1 to 831 Q253P E254G K255E E256R N257E     831/994
(83 %)
11 diff
(98.9 %id)
BQ061983 lymph, lymphoma, cell line .d 80 to 903 1 to 830 T249N K250Q T251D V252C Q253A ...     830/995
(83 %)
13 diff
(98.7 %id)
BQ065215 lymph, lymphoma, cell line .d 80 to 908 1 to 835 A203G R242P T243D G244W R245T ... AAA   835/1024
(81 %)
18 diff
(98.3 %id)
BQ066365 lymph, lymphoma, cell line .d 80 to 905 1 to 831 L237S I238H A239C A240C R241P ...     831/859
(96 %)
12 diff
(98.7 %id)
BU156987 hepatocellular carcinoma, cell line, Liver .d 80 to 910 1 to 831 T249N     831/831
(100 %)
1 diff
(99.9 %id)
BU181156 large cell carcinoma, lung .d 80 to 908 1 to 833 S223L T224H I225H R226P R227Q ...     833/932
(89 %)
14 diff
(98.5 %id)
BU163518 ductal carcinoma, cell line, Pancreas .d 80 to 908 1 to 834 G212W G213R G214W N215Q H216P ...     834/897
(92 %)
13 diff
(98.6 %id)
BU145709 ductal carcinoma, cell line, Pancreas .d 80 to 903 1 to 833 R198E V199X V202C A203G M204H ...     833/847
(98 %)
17 diff
(98.0 %id)
BQ649280 hepatocellular carcinoma, cell line, Liver .d 80 to 910 1 to 831 G212W G213R G214W N215Q H216P ... AAA   831/831
(100 %)
5 diff
(99.4 %id)
BQ642773 lymph, lymphoma, cell line .d 80 to 905 1 to 829 S223L T224H I225H R226P R227Q ...     829/913
(90 %)
8 diff
(99.2 %id)
BQ932184 epidermoid carcinoma, cell line, lung .d 80 to 905 1 to 829 G201C E254G E256K N257E AAA   829/829
(100 %)
7 diff
(99.2 %id)
BU859642 adenocarcinoma, cell line, breast .d 80 to 910 1 to 832 exact     832/895
(92 %)
3 diff
(99.7 %id)
TI_149290849   .d 81 to 905 934 to 113 G2P R3V V4Y I5P R6W ... AAA   822/967
(85 %)
15 diff
(98.5 %id)
BE018869 Kidney, renal cell adenocarcinoma .d 82 to 627 1 to 546   fully sequenced,   546/546
(100 %)
3 diff
(99.5 %id)
BQ927204 large cell carcinoma, lung .d 82 to 905 1 to 832 A203G R233P V235G T249N K250Q ... AAA   832/832
(100 %)
14 diff
(98.4 %id)
BU526858 epidermoid carcinoma, cell line, lung .d 82 to 900 1 to 835 G213S K221Q S223L T224H I225H ...     835/918
(90 %)
26 diff
(97.2 %id)
BM559066 amelanotic melanoma, cell line, skin .d 83 to 900 1 to 834 T224H R226P R227Q D228R A229C ...     834/1090
(76 %)
20 diff
(98.2 %id)
BM451331 eye, retinoblastoma .d 83 to 908 1 to 831 G212W G213R G214W N215A H216P ...     831/1049
(79 %)
15 diff
(98.6 %id)
BM462523 leiomyosarcoma, uterus .d 83 to 908 1 to 838 K234Q V235R L237S I238H A239L ...     838/1048
(79 %)
25 diff
(97.7 %id)
BQ056346 lymph, lymphoma, cell line .d 83 to 905 1 to 831 S223L T224H I225H R226P R227Q ... AAA   831/831
(100 %)
8 diff
(99.1 %id)
CR590177 Placenta Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR590460 Neuroblastoma Cot 25-normalized .d 84 to 905 1 to 822 exact     822/822
(100 %)
0 diff
(100 %id)
CR592009 fetal liver .d 84 to 904 1 to 821 exact     821/821
(100 %)
0 diff
(100 %id)
CR595877 HeLa cells Cot 25-normalized .d 84 to 902 1 to 819 exact     819/819
(100 %)
0 diff
(100 %id)
CR599063 Neuroblastoma Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR599190 HeLa cells Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR599267 thymus .d 84 to 885 1 to 802 exact     802/802
(100 %)
0 diff
(100 %id)
CR601133 Neuroblastoma Cot 10-normalized .d 84 to 861 1 to 778       778/778
(100 %)
0 diff
(100 %id)
CR601648 Placenta Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR601765 Placenta Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR603238 placenta .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR604122 Neuroblastoma Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR605549 Placenta Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR607220 Neuroblastoma Cot 10-normalized .d 84 to 878 1 to 795 exact     795/795
(100 %)
0 diff
(100 %id)
CR610036 B cells (Ramos cell line) Cot 25-normalized .d 84 to 905 1 to 822 exact     822/822
(100 %)
0 diff
(100 %id)
CR611740 T cells (Jurkat cell line) Cot10-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR614795 B cells (Ramos cell line) .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR615771 neuroblastoma .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR619989 Placenta Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR625112 T cells (Jurkat cell line) Cot10-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
CR626383 Neuroblastoma Cot 25-normalized .d 84 to 906 1 to 823 exact     823/823
(100 %)
0 diff
(100 %id)
AL520072 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 84 to 861 1 to 778   fully sequenced,   778/778
(100 %)
4 diff
(99.5 %id)
BC007935 Brain, neuroblastoma .d 84 to 907 494 to 1317 exact AAA   826/1317
(62 %)
6 diff
(99.6 %id)
BC030151 Placenta, choriocarcinoma .d 84 to 905 1 to 822 exact available from MGC, AAA   822/822
(100 %)
0 diff
(100 %id)
BU158519 embryonal carcinoma, cell line, testis .d 84 to 905 1 to 825 T249N     825/831
(99 %)
6 diff
(99.3 %id)
BU947270 insulinoma, Pancreas .d 84 to 627 9 to 552   fully sequenced,   546/554
(98 %)
6 diff
(99.0 %id)
BM561153 amelanotic melanoma, cell line, skin .d 85 to 911 1 to 835 S223L T224H I225H R226P R227Q ... AAA   835/835
(100 %)
12 diff
(98.6 %id)
BM561356 amelanotic melanoma, cell line, skin .d 85 to 911 1 to 829 G213S R242P T249N AAA   829/829
(100 %)
8 diff
(99.1 %id)
BU176157 eye, retinoblastoma .d 85 to 910 1 to 829 G201X G212W G213R G214W N215Q ...     829/837
(99 %)
9 diff
(99.0 %id)
BQ937377 epidermoid carcinoma, cell line, lung .d 85 to 905 839 to 11 A12R G13P S14G V15L F16C ... AAA Submitted on the opposite strand 829/919
(90 %)
19 diff
(98.0 %id)
BQ948033 eye, normal pigmented retinal epithelium .d 86 to 905 1 to 830 G201X A231C G232W R233A K234Q ...     830/950
(87 %)
18 diff
(98.2 %id)
BM688101 eye, human retina .d 86 to 624 9 to 544   fully sequenced,   536/544
(98 %)
11 diff
(98.0 %id)
TI_149300473   .d 87 to 905 893 to 85 G2P R3L V4I I5R R6D ... AAA   809/961
(84 %)
10 diff
(99.0 %id)
TI_149302264   .d 87 to 905 879 to 69 G2P R3L V4I I5R R6D ... AAA   811/974
(83 %)
9 diff
(99.1 %id)
TI_154052529   .d 87 to 905 892 to 86 G2P R3W V4I I5R R6D ... AAA   805/931
(86 %)
15 diff
(98.4 %id)
TI_154061869   .d 87 to 905 906 to 99 G2P R3C V4I I5R R6D ... AAA   808/1001
(80 %)
16 diff
(98.5 %id)
TI_149303311   .d 90 to 905 889 to 79 G2A R3V V4Y I5P R6* AAA   811/985
(82 %)
5 diff
(99.5 %id)
TI_149298808   .d 92 to 905 896 to 93 G2A R3V V4D I5P R6* AAA   804/932
(86 %)
14 diff
(98.5 %id)
TI_154046323   .d 92 to 907 900 to 88 G7D Q8R R9G K10R G11R ... AAA   813/977
(83 %)
3 diff
(99.7 %id)
CR624942 Neuroblastoma Cot 10-normalized .d 93 to 906 1 to 814 exact     814/814
(100 %)
0 diff
(100 %id)
TI_149288149   .d 94 to 905 914 to 108 G2C I5S R6V G7T Q8E ... AAA   807/965
(83 %)
14 diff
(98.6 %id)
BT007379   .d 98 to 871 1 to 774 I98V     774/774
(100 %)
1 diff
(99.9 %id)
CR457046   .d 98 to 870 1 to 773       773/774
(99 %)
2 diff
(99.8 %id)
CA942235 Pancreas, Purified pancreatic islet .d 100 to 408 1 to 309   fully sequenced,   309/309
(100 %)
0 diff
(100 %id)
BU952093 Pancreas, Purified pancreatic islet .d 111 to 627 1 to 517   fully sequenced,   517/517
(100 %)
0 diff
(100 %id)
CA942981 Pancreas, Purified pancreatic islet .d 111 to 627 1 to 517   fully sequenced,   517/517
(100 %)
0 diff
(100 %id)
CU445740 epidermis .d 112 to 339 231 to 3     Submitted on the opposite strand 229/286
(80 %)
0 diff
(100 %id)
BQ286255 Pancreas, Purified pancreatic islet .d 135 to 627 1 to 493   fully sequenced,   493/493
(100 %)
0 diff
(100 %id)
CA775584 Pancreas, Purified pancreatic islet .d 138 to 627 1 to 490   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
CR595000 B cells (Ramos cell line) Cot 25-normalized .d 165 to 906 1 to 742       742/742
(100 %)
0 diff
(100 %id)
CR614597 HeLa cells Cot 25-normalized .d 173 to 906 1 to 734       734/734
(100 %)
0 diff
(100 %id)
CR604065 Neuroblastoma Cot 50-normalized .d 175 to 906 1 to 732       732/732
(100 %)
0 diff
(100 %id)
CR596459 HeLa cells Cot 25-normalized .d 181 to 906 1 to 726       726/726
(100 %)
0 diff
(100 %id)
CR606016 T cells (Jurkat cell line) Cot10-normalized .d 206 to 910 1 to 705       705/705
(100 %)
0 diff
(100 %id)
CR623386 Neuroblastoma Cot 25-normalized .d 209 to 906 1 to 698       698/698
(100 %)
0 diff
(100 %id)
CR625384 T cells (Jurkat cell line) Cot10-normalized .d 235 to 906 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BY998730   .d 290 to 825 1 to 536     Submitted on the opposite strand 536/537
(99 %)
1 diff
(99.9 %id)
AA970338 colon, colon tumor .d 338 to 742 1 to 404     Submitted on the opposite strand 404/404
(100 %)
24 diff
(94.1 %id)
AW157656 brain, frontal lobe .d 347 to 905 570 to 11   fully sequenced, AAA   560/560
(100 %)
1 diff
(99.9 %id)
CA844026 Pancreas, Purified pancreatic islet .d 347 to 906 562 to 3   fully sequenced,   560/562
(99 %)
0 diff
(100 %id)
DN949389.
matches multiple genes
Pancreas, Purified pancreatic islet .d 424 to 905 500 to 19   AAA Submitted on the opposite strand, also hits gene LRRC1 482/482
(100 %)
0 diff
(100 %id)
AA226666   .d 427 to 728 304 to 1       304/304
(100 %)
4 diff
(98.7 %id)
BQ350773 head_neck .d 428 to 750 333 to 5       329/335
(98 %)
18 diff
(94.7 %id)
CA388833 eye, RPE/choroid .d 429 to 905 502 to 26   fully sequenced, AAA   477/477
(100 %)
2 diff
(99.6 %id)
EC578499 Prostate .d 435 to 512 80 to 5       76/89
(85 %)
0 diff
(100 %id)
BU731549 eye, RPE and Choroid .d 454 to 907 472 to 19   fully sequenced, AAA   454/454
(100 %)
0 diff
(100 %id)
AW162428 brain, frontal lobe .d 472 to 905 444 to 11   fully sequenced, AAA   434/434
(100 %)
0 diff
(100 %id)
BE302311 cervix .d 472 to 906 435 to 1   fully sequenced,   435/435
(100 %)
0 diff
(100 %id)
CU443221 epidermis .d 474 to 861 399 to 13     Submitted on the opposite strand 387/400
(96 %)
5 diff
(98.8 %id)
CU446854 epidermis .d 474 to 861 399 to 13     Submitted on the opposite strand 387/400
(96 %)
5 diff
(98.8 %id)
CU447547 epidermis .d 474 to 780 321 to 14     Submitted on the opposite strand 308/322
(95 %)
5 diff
(98.5 %id)
CU456607 epidermis .d 474 to 861 399 to 13     Submitted on the opposite strand 387/400
(96 %)
6 diff
(98.5 %id)
CU445658 epidermis .d 480 to 780 314 to 14     Submitted on the opposite strand 301/320
(94 %)
4 diff
(98.8 %id)
CU448658 epidermis .d 480 to 780 314 to 14     Submitted on the opposite strand 301/320
(94 %)
4 diff
(98.8 %id)
CU453579 epidermis .d 480 to 861 393 to 13     Submitted on the opposite strand 381/399
(95 %)
5 diff
(98.8 %id)
AL561848 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 566 to 861 296 to 1   fully sequenced,   296/296
(100 %)
0 diff
(100 %id)
BE206557 Kidney, renal cell adenocarcinoma .d 566 to 905 352 to 13   fully sequenced, AAA   340/340
(100 %)
0 diff
(100 %id)
BQ269614 Pancreas, Purified pancreatic islet .d 566 to 904 339 to 1   fully sequenced,   339/339
(100 %)
0 diff
(100 %id)
BU948762 Pancreas, Purified pancreatic islet .d 566 to 904 339 to 1   fully sequenced,   339/339
(100 %)
0 diff
(100 %id)
BU951836 Pancreas, Purified pancreatic islet .d 566 to 906 341 to 1   fully sequenced,   341/341
(100 %)
0 diff
(100 %id)
BU786063 insulinoma, Pancreas .d 566 to 905 357 to 18   fully sequenced, AAA   340/340
(100 %)
0 diff
(100 %id)
BU952538 Pancreas, Purified pancreatic islet .d 566 to 906 343 to 3   fully sequenced,   341/343
(99 %)
0 diff
(100 %id)
CA775305 Pancreas, Purified pancreatic islet .d 566 to 906 343 to 3   fully sequenced,   341/343
(99 %)
0 diff
(100 %id)
CA942746 Pancreas, Purified pancreatic islet .d 566 to 904 339 to 1   fully sequenced,   339/339
(100 %)
0 diff
(100 %id)
BU726808 eye, human retina .d 566 to 905 358 to 19   fully sequenced, AAA   340/340
(100 %)
0 diff
(100 %id)
GD157813   .d 707 to 905 1 to 199   AAA   199/199
(100 %)
11 diff
(94.5 %id)
GD138139   .d 714 to 904 10 to 199   AAA   190/200
(95 %)
6 diff
(97.0 %id)
GD138178   .d 715 to 905 8 to 198   AAA   191/198
(96 %)
6 diff
(97.0 %id)
DW438668 Liver .d 729 to 905 228 to 52   AAA   177/193
(91 %)
1 diff
(99.5 %id)
EC486052 Prostate .d 739 to 838 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
AI970791 normal prostate, Prostate .d 769 to 906 138 to 1       138/138
(100 %)
7 diff
(95.0 %id)
FN077075 breast carcinoma .d 774 to 860 91 to 1     Submitted on the opposite strand 91/91
(100 %)
4 diff
(95.7 %id)
EC584177 Prostate .d 800 to 903 117 to 13       105/117
(89 %)
0 diff
(100 %id)
EC498710 Prostate .d 812 to 902 95 to 5       91/95
(95 %)
0 diff
(100 %id)
EC457210 Prostate .d 817 to 903 87 to 5       83/87
(95 %)
0 diff
(100 %id)
AA129539 lung, lung carcinoma .d 824 to 903 82 to 1     Submitted on the opposite strand 82/89
(92 %)
2 diff
(97.8 %id)
BM850604 stomach .e 1 to 477 1 to 477   tiling clone,   477/477
(100 %)
0 diff
(100 %id)
BF724913 eye, Iris .e 14 to 477 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BM840954 lymph node, stomach .e 31 to 492 1 to 462       462/485
(95 %)
6 diff
(98.8 %id)
BM840401 lymph node, stomach .e 33 to 477 1 to 445       445/445
(100 %)
0 diff
(100 %id)
CF780581 Pooled Chondrosarcoma Tumor cells .e 42 to 480 7 to 445       439/493
(89 %)
0 diff
(100 %id)
BE268513 Burkitt lymphoma, lymph .e 43 to 723 20 to 696   tiling clone,   677/726
(93 %)
14 diff
(98.1 %id)
CB123216 Liver .e 43 to 479 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
AA313540 colon .e 50 to 492 1 to 445       447/456
(98 %)
15 diff
(96.8 %id)
BE397820 Burkitt lymphoma, lymph .e 50 to 754 2 to 712 K169R A170Q K171R R172G N173T ...     722/726
(99 %)
68 diff
(90.7 %id)
BE279648 choriocarcinoma, placenta .e 67 to 478 1 to 412       412/414
(99 %)
0 diff
(100 %id)
BP422038 small intestine .e 68 to 480 17 to 429     Submitted on the opposite strand 413/470
(87 %)
12 diff
(97.5 %id)
BE264845 lung, small cell carcinoma .e 69 to 480 1 to 412       412/449
(91 %)
0 diff
(100 %id)
AA308132 colon .e 71 to 478 1 to 408       408/408
(100 %)
4 diff
(99.1 %id)
DW427422 Liver .e 217 to 479 17 to 279       263/279
(94 %)
6 diff
(97.9 %id)
BE905175 epithelioid carcinoma, Pancreas .e 228 to 480 1 to 252       252/292
(86 %)
1 diff
(99.7 %id)
EC487604 Prostate .e 400 to 480 1 to 81       81/103
(78 %)
0 diff
(100 %id)
BG170817 hypernephroma, cell line, Kidney .f 1 to 711 30 to 737   tiling clone,   711/779
(91 %)
18 diff
(97.7 %id)
TI_59392845   .f 181 to 898 48 to 763   tiling clone,   716/1100
(65 %)
5 diff
(99.6 %id)
BM014786 breast, mammary adenocarcinoma, cell line .f 182 to 898 1 to 715   tiling clone,   715/729
(98 %)
5 diff
(99.4 %id)
BG703768 brain, hippocampus .f 199 to 858 1 to 660   tiling clone,   660/660
(100 %)
7 diff
(99.0 %id)
CN424138 embryonic stem cells, DMSO-treated H9 cellline .g 1 to 623 1 to 617   tiling clone,   617/617
(100 %)
1 diff
(99.9 %id)
BF204648 muscle, rhabdomyosarcoma .g 5 to 623 1 to 610       610/610
(100 %)
5 diff
(99.2 %id)
CR612339 fetal brain .g 11 to 725 1 to 715 exact tiling clone,   715/715
(100 %)
0 diff
(100 %id)
BU602829 mixed (pool of 40 RNAs) .g 150 to 724 1 to 570       570/574
(99 %)
1 diff
(99.9 %id)
BQ070831 brain, neuroblastoma, cell line .h 1 to 699 1 to 699 G93W V119G Q215H tiling clone,   699/720
(97 %)
6 diff
(99.2 %id)
AA226667   .h 22 to 491 1 to 467   tiling clone,   467/467
(100 %)
6 diff
(98.8 %id)
R58227   .h 32 to 184 1 to 149       149/150
(99 %)
13 diff
(91.4 %id)
TI_149287291   .i 1 to 642 736 to 95 H2D G17D AAA   642/701
(91 %)
3 diff
(99.6 %id)
BM972632 lung .i 1 to 642 660 to 19 H2D G17D tiling clone, AAA   642/644
(99 %)
3 diff
(99.6 %id)
TI_57201925   .j 1 to 774 41 to 817 exact     783/817
(95 %)
13 diff
(98.5 %id)
BI822037 pooled brain, lung, testis .j 1 to 774 5 to 781 exact tiling clone,   781/781
(100 %)
7 diff
(99.2 %id)
AL561279 B cells from Burkitt lymphoma .k 1 to 906 4 to 908 L32C R33A A34P V35W D36I ... fully sequenced,   908/908
(100 %)
3 diff
(99.7 %id)
CR623747 B cells (Ramos cell line) Cot 25-normalized .k 1 to 906 4 to 909 exact tiling clone,   909/909
(100 %)
0 diff
(100 %id)
AI832811 colon .k 431 to 905 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
AL561278 B cells from Burkitt lymphoma .k 480 to 847 368 to 1   fully sequenced,   368/368
(100 %)
1 diff
(99.8 %id)
DA040045 bladder .l 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
6 diff
(99.0 %id)
BU630038 cell lines, Chondrosarcoma .l 434 to 1112 694 to 19 N45K tiling clone, AAA   676/677
(99 %)
4 diff
(99.5 %id)
CU453492 epidermis .l 530 to 857 19 to 346   tiling clone,   328/352
(93 %)
14 diff
(96.1 %id)
CF124019 CNCAP(3)T-225 cell line, Prostate .m 1 to 385 158 to 542       393/542
(72 %)
5 diff
(99.1 %id)
TI_154184210   .m 1 to 559 227 to 784 R57X G107X G108V N109A H110T ... tiling clone,   566/1084
(52 %)
11 diff
(99.0 %id)
BG542881 lung .m 6 to 560 1 to 554 R136G T137L G138D R139V L140S ... tiling clone,   554/739
(74 %)
6 diff
(99.2 %id)
BM090626 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .n 1 to 437 7 to 448       453/448
(101 %)
9 diff
(98.0 %id)
BM090634 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .n 1 to 472 5 to 476 exact tiling clone,   476/476
(100 %)
1 diff
(99.8 %id)
BM090867 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .n 62 to 488 427 to 1   tiling clone,   427/427
(100 %)
0 diff
(100 %id)
BM090852 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .n 135 to 488 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
AU102713   .o 1 to 50 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BU597221 mixed (pool of 40 RNAs) .o 1 to 549 1 to 549 G139X tiling clone,   549/551
(99 %)
2 diff
(99.7 %id)
DW459994 Liver .o 24 to 153 11 to 142       132/142
(92 %)
11 diff
(92.3 %id)
AU102714   .o 27 to 76 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
FN134831 breast carcinoma .o 31 to 119 1 to 90       90/90
(100 %)
6 diff
(93.4 %id)
AU102715   .o 35 to 84 1 to 50       50/50
(100 %)
0 diff
(100 %id)
FN109520 breast carcinoma .o 56 to 137 82 to 1     Submitted on the opposite strand 82/91
(90 %)
3 diff
(96.8 %id)
FN118013 breast carcinoma .o 126 to 208 92 to 12     Submitted on the opposite strand 81/92
(88 %)
0 diff
(100 %id)
AI971487 pooled germ cell tumors .o 127 to 555 435 to 7       429/435
(98 %)
9 diff
(98.0 %id)
AA582713 colon, tumor .o 191 to 545 358 to 4       355/358
(99 %)
21 diff
(94.2 %id)
CV397753 kidney_tumor .o 204 to 483 284 to 3     Submitted on the opposite strand 282/284
(99 %)
0 diff
(100 %id)
BG166303 hypernephroma, cell line, Kidney .o 204 to 550 1 to 347   tiling clone, AAA   347/347
(100 %)
0 diff
(100 %id)
F24789 pectoral muscle (after mastectomy) .o 205 to 550 1 to 346   AAA   346/346
(100 %)
1 diff
(99.8 %id)
AI129959 uterus .o 206 to 555 356 to 7       350/356
(98 %)
0 diff
(100 %id)
F20265 pectoral muscle (after mastectomy) .o 206 to 510 1 to 306       306/306
(100 %)
4 diff
(98.7 %id)
TI_57229778   .o 207 to 550 49 to 392   AAA   344/344
(100 %)
0 diff
(100 %id)
TI_57189608   .o 215 to 550 46 to 381   AAA   336/381
(88 %)
6 diff
(98.5 %id)
AA661731 normal prostate, Prostate .o 221 to 421 229 to 25       205/229
(89 %)
12 diff
(94.8 %id)
T49986 placenta .o 240 to 545 1 to 320       320/334
(95 %)
19 diff
(94.4 %id)
BF794478 lymph, lymphoma, cell line .o 256 to 550 1 to 295   AAA   295/295
(100 %)
0 diff
(100 %id)
BE166741 head_neck .o 297 to 459 1 to 164       164/164
(100 %)
18 diff
(89.1 %id)
EC527712 Prostate .o 299 to 401 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
EC506907 Prostate .o 302 to 402 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
EC467493 Prostate .o 303 to 402 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
EC505929 Prostate .o 303 to 402 1 to 96       96/96
(100 %)
6 diff
(93.8 %id)
EC507315 Prostate .o 303 to 402 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
BE166743 head_neck .o 307 to 459 1 to 152       152/152
(100 %)
13 diff
(91.5 %id)
EC457895 Prostate .o 308 to 407 1 to 98       98/98
(100 %)
5 diff
(94.9 %id)
EC502050 Prostate .o 308 to 402 11 to 105       95/105
(90 %)
6 diff
(94.3 %id)
EC478479 Prostate .o 316 to 410 1 to 92       92/96
(95 %)
5 diff
(94.8 %id)
EC509173 Prostate .o 322 to 420 3 to 97       95/97
(97 %)
8 diff
(91.8 %id)
EC563229 Prostate .o 322 to 420 1 to 98       98/98
(100 %)
6 diff
(93.9 %id)
EC470686 Prostate .o 331 to 429 1 to 96       96/96
(100 %)
8 diff
(91.7 %id)
EC444269 Prostate .o 337 to 429 1 to 96       93/96
(96 %)
9 diff
(90.7 %id)
AW609895 stomach .o 338 to 484 169 to 28       142/169
(84 %)
0 diff
(100 %id)
EC487207 Prostate .o 350 to 429 21 to 100       80/100
(80 %)
0 diff
(100 %id)
BE407726 choriocarcinoma, placenta .p 1 to 539 1 to 541 exact tiling clone, AAA   541/541
(100 %)
3 diff
(99.5 %id)
DB023280 testis .q 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
4 diff
(99.3 %id)
DA812791 Pancreas .q 7 to 692 2 to 686 K21S H22T R23V G25A A26L ... tiling clone, capped   685/700
(97 %)
10 diff
(98.6 %id)
DB336194 testis .q 822 to 1419 600 to 1   tiling clone,   600/601
(99 %)
4 diff
(99.4 %id)
DB327449 Pancreas .q 865 to 1419 560 to 1   tiling clone,   560/561
(99 %)
21 diff
(96.3 %id)
AK309619   .r 1 to 1007 1 to 1007 exact tiling clone,   1007/1007
(100 %)
2 diff
(99.9 %id)
DA661229   .r 2 to 560 2 to 560 exact capped   559/559
(100 %)
2 diff
(99.7 %id)
DA038972 bladder .r 7 to 558 2 to 551 I48H I49P H50R D51P P52G ... tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
DA630574 Kidney .r 26 to 583 2 to 559 exact capped   558/558
(100 %)
1 diff
(99.9 %id)
CX787638 human embryonic stem cells .r 44 to 772 1 to 729 exact tiling clone,   729/729
(100 %)
1 diff
(99.9 %id)
CR986028 T-Lymphocytes .r 56 to 581 1 to 526 exact     526/526
(100 %)
0 diff
(100 %id)
TI_57237116   .r 64 to 912 29 to 897 R9S K10E A12R G13R S14V ...     869/899
(96 %)
58 diff
(93.6 %id)
BI911082 leukocyte .r 70 to 912 1 to 863       863/865
(99 %)
55 diff
(93.7 %id)
BG996993 head_neck .s 1 to 254 1 to 253   tiling clone,   253/253
(100 %)
8 diff
(96.9 %id)
BM997153 Chondrosarcoma, Left Pubic Bone .s 45 to 711 687 to 19 exact tiling clone, AAA   669/669
(100 %)
3 diff
(99.6 %id)
BF896377 marrow .s 122 to 279 158 to 1     Submitted on the opposite strand 158/158
(100 %)
8 diff
(95.0 %id)
BF816294 colon_ins .s 185 to 417 12 to 244       233/247
(94 %)
3 diff
(98.8 %id)
AW009941 colon .s 204 to 711 508 to 1 exact     508/508
(100 %)
0 diff
(100 %id)
AI559194 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .s 281 to 712 436 to 5 exact tiling clone,   432/436
(99 %)
0 diff
(100 %id)
AK301073 Spleen Gene RPL8, variant not shown         Suspected internal deletion, this clone was ignored    
284 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI